Vaccination three times with 104 IU VRP-neu (P = 0.0265) or twice with 105 IU VRP-neu (P = 0.0079) was sufficient to prevent tumor growth of A2L2 cells injected into a mammary fat pad (Fig. 3a). This evidence concerns the gene ERBB2 and neoplasm.